Last reviewed · How we verify
NCT07109492
The Role of Mandala Painting Before Surgery
NA trial testing Mandala in Mandala Painting in 60 participants. Currently enrolling.
1 July 2026
Quick facts
| Lead sponsor | Niran Çoban |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 1 July 2025 |
| Primary completion | 1 July 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Mandala
Conditions studied
- Mandala Painting — all drugs for Mandala Painting →
- Surgery — all drugs for Surgery →
- Nurse's Role — all drugs for Nurse's Role →
Sponsor
Niran Çoban
Who can join
Adults 18 to 70, any sex, with Mandala Painting or Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Surgical interventions often cause significant anxiety and stress in patients during the preoperative period. In this study, it is aimed to determine the effect of mandala coloring, a non-pharmacological and art-based intervention, on reducing anxiety and stress levels in individuals scheduled for elective surgery. The universe of the study will consist of patients who will undergo elective surgery between June 2025 and June 2026 in the General Surgery Clinic of Istanbul Sultangazi Training and Research Hospital. Data will be collected using the Introductory Information Form, State Anxiety Inventory (STAI-S), Perceived Stress Scale (PSS), and Physiological Parameters Form (including blood pressure, pulse, respiration rate, and oxygen saturation). One day before surgery, patients who meet the inclusion criteria will be informed about the study and randomized into intervention and control groups using a random number table created with MS Excel software. Patients in the intervention group will perform a 20-minute mandala coloring activity in the preoperative waiting period. Before and after the application, participants' anxiety and stress levels will be evaluated with the STAI-S and PSS, and their physiological parameters will be recorded. Patients in the control group will receive standard preoperative care and will be evaluated at the same time points with the same tools, without any intervention. The study aims to provide evidence for the use of mandala coloring as a simple, low-cost, and effective nursing intervention to reduce preoperative anxiety and stress.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07109492
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mandala
Trials testing the same drug.
- NCT06122168 — "Sweet Expectation and Positive Thinking" the Use of the Mandala in the Induction of Labor · NA · completed
- NCT06735456 — The Effect of Mandala on Anxiety, Physiological Parameters and Patient Satisfaction in Women With Breast Cancer · NA · completed
- NCT06180343 — The Effect of Mandala Coloring on Students' Anxiety Level and Quality of Life · NA · unknown
- NCT05307224 — The Effect of Mandala Painting on Anxiety in Coronary Heart Patients · NA · completed
- NCT06132022 — The Effect of Mandala Application on Anxiety Level and Caregiver Burden in Palliative Care · NA · completed
Other Niran Çoban trials
Trials by the same sponsor.
- NCT07109557 — The Effect of Baduanjin on Patients Undergoing Knee Replacement Surgery · NA · recruiting
- NCT07171008 — The Effect of Ney Music on Patients Undergoing Lumbar Disc Surgery · NA · recruiting
- NCT05711706 — Su Jok Application in After Lumbar Disc Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07109492 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Niran Çoban
- Last refreshed: 28 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07109492.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing